ArticleFrontiers in pharmacology2021

Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans.

Cynthia L Bristow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.